Design and Synthesis of Novel Isoquinoline-3-Nitriles as Orally Bioavailable Kv1.5 Antagonists for the Treatment of Atrial Fibrillation

doi 10.1021/jm060927v.s001

Full Text

Abstract

Available in

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Novel, Orally Bioavailable G-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists

English

Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A1 Receptor Antagonists

English

Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B1 Receptor Antagonists

English

Fragment-Based Drug Design and Identification of HJC0123 , a Novel Orally Bioavailable STAT3 Inhibitor for Cancer Therapy

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2013English

Dronedarone for the Treatment of Atrial Fibrillation and Atrial Flutter

Health Technology Assessment
MedicineHealth Policy
2010English

Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-Ht1a Agonists/5-Ht3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS)

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2009English

Cardiac Radiosurgery for the Treatment of Atrial Fibrillation

World Journal of Cardiovascular Diseases
2016English

Design, Synthesis, and Structure-Activity Relationships of Thieno[2, 3-B]pyridin-4-One Derivatives as a Novel Class of Potent, Orally Active, Non-Peptide Luteinizing Hormone-Releasing Hormone Receptor Antagonists

English

The Surgical Treatment of Atrial Fibrillation

Surgical Clinics of North America
Surgery
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy